Reporting of sex-specific outcomes in trials of interventions for cardiovascular disease: Has there been progress?

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

In the past decade, the leading international cardiology societies have released statements that emphasize the importance of sex-specific reporting of the findings of clinical trials in cardiovascular research. To find out whether this has led to improvement, we compared sex-specific reporting of efficacy and safety outcomes for trials of cardiovascular drug interventions presented at the major clinical trials sessions of the European Society of Cardiology (ESC), American Heart Association (AHA) and the American College of Cardiology (ACC) before and after publication of these statements. We found that sex-specific efficacy and safety outcomes of the most influential cardiovascular intervention trials are still not systematically presented.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalMaturitas
Volume144
DOIs
Publication statusPublished - Feb 2021

Fingerprint

Dive into the research topics of 'Reporting of sex-specific outcomes in trials of interventions for cardiovascular disease: Has there been progress?'. Together they form a unique fingerprint.

Cite this